Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Chemours Co

CC

Chemours Co

Chemours Co historical holders

total: 5

Greenlight Capital Chemours Co transactions over time

Total transactions:
26
New positions:
3
Sold out:
3
Added:
6
Reduced:
14
Held since:
2019 Q2
Held for:
13 quarters
Latest activity:
2022 Q3
David Einhorn has been an institutional investor in Chemours Co (CC) since 2015 Q4. According to 2026 Q1 report, David Einhorn doesn't hold any shares. The fund/company first acquired CC in 2015 Q4, initially purchasing about 3.40M shares. David Einhorn later completely sold out the position and reinvested in CC again in 2019 Q2. Since the initial investment, Greenlight Capital has made 25 more transactions in this position.

When did David Einhorn exit their CC position?

David Einhorn no longer holds Chemours Co (CC). They sold off their entire position in 2022 Q3, closing out an investment that began in 2015 Q4.

When did David Einhorn first invest in CC?

David Einhorn first invested in Chemours Co (CC) in 2015 Q4 at the reported quarter-end price of $5.36 per share, acquiring 3,400,000 shares in their initial purchase.

What is David Einhorn's average cost basis for CC?

Based on historical transaction data, David Einhorn's estimated cost basis for Chemours Co (CC) is approximately $20.87 per share. This represents their average reported price* across all buy transactions.

Has David Einhorn reinvested in CC after selling?

Yes, David Einhorn has shown renewed interest in Chemours Co (CC). After completely selling their position, they reinitiated an investment in 2019 Q2, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$20.87
Weighted AVG sell price:
$21.46

CC transactions history by Greenlight Capital

26 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2022 Q3
0.00%
0
$32.02
-100% (-700,000)
-1.74%
2022 Q2
1.74%
700,000
$32.02
$22,413,000
-67.32% (-1,441,814)
-2.93%
2022 Q1
4.28%
2,141,814
$31.48
$67,424,000
+22.96% (+400,000)
+0.8%
2021 Q4
3.56%
1,741,814
$33.56
$58,456,000
-25.00% (-580,605)
-1.31%
2021 Q3
4.53%
2,322,419
$29.06
$67,489,000
-0.39% (-9,160)
-0.02%
2021 Q2
5.09%
2,331,579
$34.80
$81,139,000
+4.48% (+100,000)
+0.22%
2021 Q1
4.34%
2,231,579
$27.91
$62,284,000
-14.08% (-365,670)
-0.62%
2020 Q4
3.93%
$24.79
-14.76% (-449,700)
2020 Q3
5.26%
$20.91
-10.28% (-349,000)
2020 Q2
5.70%
$15.35
-30.46% (-1,487,600)
2020 Q1
6.22%
$8.87
-28.30% (-1,927,194)
2019 Q4
9.14%
$18.09
+5.05% (+327,402)
2019 Q3
6.97%
$14.94
+74.20% (+2,761,518)
2019 Q2
6.59%
$24.00
new
2019 Q1
0.00%
$28.22
-100% (-200,000)
2018 Q4
0.41%
$28.22
new
2018 Q1
0.00%
$50.06
-100% (-1,048,100)
2017 Q4
0.95%
$50.06
-29.42% (-436,900)
2017 Q3
1.22%
$50.61
-58.79% (-2,118,070)
2017 Q2
2.20%
$37.92
-27.94% (-1,396,930)
2017 Q1
2.94%
$38.50
-44.10% (-3,945,144)
2016 Q4
3.99%
$22.09
-45.35% (-7,422,042)
2016 Q3
5.01%
$16.00
-0.26% (-42,700)
2016 Q2
2.48%
$8.24
+85.58% (+7,567,286)
2016 Q1
1.05%
$7.00
+160.08% (+5,442,600)
2015 Q4
0.33%
$5.36
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.